Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | MPO | P05164 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | ACE | P12821 | 3/20 | 0.59 |
| ▸ | ECE1 | P42892 | 6/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2545492 | 1.00 | CTSC (0.67) | CTSCMEN1KMT2AKDM4ELMNA | |
| SCHEMBL28334124 | 1.00 | CTSC (0.67) | CTSCMEN1KMT2AKDM4ELMNA | |
| SCHEMBL30051770 | 0.98 | CTSC (0.65) | CTSCMEN1KMT2AKDM4ELMNA | |
| SCHEMBL30052009 | 0.97 | CTSC (0.64) | CTSCMEN1KMT2AKDM4ELMNA | |
| SCHEMBL30051220 | 0.95 | CTSC (0.62) | CTSCMEN1KMT2AKDM4ELMNA | |
| SCHEMBL30051511 | 0.95 | CTSC (0.64) | CTSCMEN1KMT2AKDM4ELMNA | |
| SCHEMBL30051910 | 0.94 | CTSC (0.61) | CTSCMEN1KMT2AKDM4ELMNA | |
| SCHEMBL30051560 | 0.93 | CTSC (0.60) | CTSCMEN1KMT2AKDM4ELMNA | |
| SCHEMBL30051343 | 0.93 | ERAP2 (0.63) | CTSCMEN1KMT2AACEECE1 | |
| SCHEMBL30053106 | 0.93 | CTSC (0.69) | CTSCMEN1KMT2AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5212069-A | Forming dipeptides from amides and glycine, cysteine or methionine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1993-05-18 | — | — | US | claimed |
| EP-0381997-A1 | Microbially prepared N-acetyl-2,3-didehydroleucine acylase, process for its preparation and its use | Degussa Aktiengesellschaft (DE) | 1990-08-16 | — | — | EP | claimed |
| EP-2413711-B1 | DIPEPTIDE AS FEEDSTUFF ADDITIVE | EVONIK DEGUSSA GMBH (DE) | 2014-08-06 | — | — | EP | disclosed |
| US-20140205711-A1 | DIPEPTIDES AS FEED ADDITIVES | EVONIK DEGUSSA GMBH (DE) | 2014-07-24 | — | — | US | disclosed |
| US-20140205711-A1 | DIPEPTIDES AS FEED ADDITIVES | EVONIK DEGUSSA GMBH (DE) | 2014-07-24 | — | — | US | disclosed |
| WO-2010112365-A1 | DIPEPTIDE AS FEEDSTUFF ADDITIVE | EVONIK DEGUSSA GMBH (DE) | 2010-10-07 | — | — | WO | disclosed |
| US-20100247707-A1 | DIPEPTIDES AS FEED ADDITIVES | EVONIK DEGUSSA GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
| US-20100247707-A1 | DIPEPTIDES AS FEED ADDITIVES | EVONIK DEGUSSA GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
| US-5212069-A | Forming dipeptides from amides and glycine, cysteine or methionine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1993-05-18 | — | — | US | disclosed |
| US-5212069-A | Forming dipeptides from amides and glycine, cysteine or methionine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1993-05-18 | — | — | US | disclosed |
| US-5134073-A | Culture product of zoogloea ramigera | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1992-07-28 | — | — | US | disclosed |
| EP-0381997-A1 | Microbially prepared N-acetyl-2,3-didehydroleucine acylase, process for its preparation and its use | Degussa Aktiengesellschaft (DE) | 1990-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247707-A1 | DIPEPTIDES AS FEED ADDITIVES | AADAT, BCAT2, SLC7A11 | CTSC 513/4885MEN1 1811/4885KMT2A 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.